Article Text

Download PDFPDF
Letter to the editor
Caution during use of desmopressin in IPSS
  1. Francesca Pecori Giraldi1,2,
  2. Augusto B Federici2,3,
  3. Francesco Cavagnini1
  1. 1Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano, Milan, Italy
  2. 2Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
  3. 3L. Sacco University Hospital, Milan, Italy
  1. Correspondence to Dr Francesca Pecori Giraldi, Neuroendocrinology Research Laboratory, Istituto Auxologico Italiano IRCCS, Milan, Italy; fpg{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest the paper by Dr Oklu and coworkers on the use of desmopressin during inferior petrosal sinus sampling (IPSS) as an alternative to corticotropin-releasing hormone (CRH) for the diagnostic investigation of Cushing's disease.1 As the authors report, evidence collected in small series suggests that desmopressin achieves …

View Full Text


  • Contributors All authors contributed equally.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles